Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID®

NCT01352585 · clinicaltrials.gov ↗

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Thrombocythemia (ET)

Interventions

DRUG: Anagrelide hydrochloride

Sponsor

Shire